Assessment of glycemic control: New insights into the evaluation of the diabetic patient;Parámetros de control glucémico: nuevas perspectivas en la evaluación del diabético

Medicina Clinica

Volumn 135, Issue SUPPL. 2, 2010, Pages 15-19

  González Clemente, José Miguel ^a   Cabot, Gemma Llauradó ^a  

^a HOSPITAL DE SABADELL   (Spain)

Author keywords

Fasting plasma glucose; Glycemic control; Glycemic variability; Glycosylated hemoglobin; Postprandial glucose; Type 2 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ARTICLE; CHRONIC DISEASE; CLINICAL DECISION MAKING; DIAGNOSTIC ACCURACY; EVIDENCE BASED MEDICINE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; MICROANGIOPATHY; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; RISK REDUCTION;

EID: 79952914109     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2009.11.041     Document Type: Article

References (55)

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus The Diabetes Control and Complications Trial Research Group N Engl J Med 329 1993 977 986
2. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group Lancet 352 1998 837 853
3. REFEffect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group Lancet 352 1998 854 865
4. D.M. Nathan, P.A. Cleary, J.Y. Backlund, S.M. Genuth, J.M. Lachin, and T.J. Orchard Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes N Engl J Med 353 2005 2643 2653 (Pubitemid 41817713)
5. R.R. Holman, S.K. Paul, M.A. Bethel, D.R. Matthews, and H.A. Neil 10-year follow-up of intensive glucose control in type 2 diabetes N Engl J Med 359 2008 1577 1589
6. M. Brownlee, and I.B. Hirsch Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications JAMA 295 2006 1707 1708
7. A. Ceriello, M. Hanefeld, L. Leiter, L. Monnier, A. Moses, and D. Owens Postprandial glucose regulation and diabetic complications Arch Intern Med 164 2004 2090 2095 (Pubitemid 39410797)
8. L. Monnier, C. Colette, and D.R. Owens Integrating glycaemic variability in the glycaemic disorders of type 2 diabetes: a move towards a unified glucose tetrad concept Diabetes Metab Res Rev 25 2009 393 402
9. American Diabetes Association Standards of medical care in diabetes - 2009 Diabetes Care 32 Suppl 1 2009 S13 S61
10. D.B. Sacks, D.E. Bruns, D.E. Goldstein, N.K. Maclaren, J.M. McDonald, and M. Parrott Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus Clin Chem 48 2002 436 472 (Pubitemid 34174577)
11. D.E. Goldstein, R.R. Little, R.A. Lorenz, J.I. Malone, D. Nathan, and C.M. Peterson Tests of glycemia in diabetes Diabetes Care 27 2004 1761 1773 (Pubitemid 38857461)
12. Consensus statement on the worldwide standardization of the hemoglobin A1C measurement: the American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and the International Diabetes Federation Diabetes Care 30 2007 2399 2400
13. C.L. Rohlfing, H.M. Wiedmeyer, R.R. Little, J.D. England, A. Tennill, and D.E. Goldstein Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial Diabetes Care 25 2002 275 278 (Pubitemid 41079621)
14. D.M. Nathan, H. Turgeon, and S. Regan Relationship between glycated haemoglobin levels and mean glucose levels over time Diabetologia 50 2007 2239 2244 (Pubitemid 47512407)
15. D.M. Nathan, J. Kuenen, R. Borg, H. Zheng, D. Schoenfeld, and R.J. Heine Translating the A1C assay into estimated average glucose values Diabetes Care 31 2008 1473 1478
16. A. Avignon, A. Radauceanu, and L. Monnier Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes Diabetes Care 20 1997 1822 1826 (Pubitemid 27522889)
17. M. Bouma, J.H. Dekker, J.J. De Sonnaville, F.E. Van der Does, H. De Vries, and D.M. Kriegsman How valid is fasting plasma glucose as a parameter of glycemic control in non-insulin-using patients with type 2 diabetes? Diabetes Care 22 1999 904 907 (Pubitemid 29241042)
18. I.M. El-Kebbi, D.C. Ziemer, C.B. Cook, D.L. Gallina, C.S. Barnes, and L.S. Phillips Utility of casual postprandial glucose levels in type 2 diabetes management Diabetes Care 27 2004 335 339 (Pubitemid 38174054)
19. L. Monnier, H. Lapinski, and C. Colette Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c) Diabetes Care 26 2003 881 885 (Pubitemid 36929359)
20. Diabetes Research in Children Network (DIRECNET) Study Group Relationship of A1C to glucose concentrations in children with type 1 diabetes: assessments by high-frequency glucose determinations by sensors Diabetes Care 31 2008 381 385
21. I.M. Stratton, A.I. Adler, H.A. Neil, D.R. Matthews, S.E. Manley, and C.A. Cull Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study BMJ 321 2000 405 412 (Pubitemid 30609442)
22. H.C. Gerstein, M.E. Miller, R.P. Byington, D.C. Goff Jr, J.T. Bigger, and J.B. Buse Effects of intensive glucose lowering in type 2 diabetes N Engl J Med 358 2008 2545 2559 (Pubitemid 351831356)
23. A. Patel, S. MacMahon, J. Chalmers, B. Neal, L. Billot, and M. Woodward Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes N Engl J Med 358 2008 2560 2572 (Pubitemid 351831357)
24. W. Duckworth, C. Abraira, T. Moritz, D. Reda, N. Emanuele, and P.D. Reaven Glucose control and vascular complications in veterans with type 2 diabetes N Engl J Med 360 2009 129 139
25. D.M. Nathan, J.B. Buse, M.B. Davidson, E. Ferrannini, R.R. Holman, and R. Sherwin Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes Diabetes Care 32 2009 193 203
26. IDF Clinical Guidelines Task Force Global Guideline for Type 2 Diabetes: recommendations for standard, comprehensive, and minimal care Diabet Med 23 2006 579 593
27. S. Genuth, K.G. Alberti, P. Bennett, J. Buse, R. Defronzo, and R. Kahn Follow-up report on the diagnosis of diabetes mellitus Diabetes Care 26 2003 3160 3167 (Pubitemid 37339514)
28. R.I. Shorr, L.V. Franse, H.E. Resnick, M. Di Bari, K.C. Johnson, and M. Pahor Glycemic control of older adults with type 2 diabetes: findings from the Third National Health and Nutrition Examination Survey, 1988-1994 J Am Geriatr Soc 48 2000 264 267 (Pubitemid 30164208)
29. J. Arroyo, X. Badía, H. De la Calle, J. Díez, E. Esmatjes, and I. Fernández Tratamiento de los pacientes con diabetes mellitus tipo 2 en atención primaria en España Med Clin (Barc) 125 2005 166 172 (Pubitemid 41112939)
30. F.J. Del Cañizo Gómez, and M.N. Moreira Andrés Control estricto de los factores de riesgo cardiovascular modificables en pacientes con diabetes mellitus tipo 2 Med Clin (Barc) 130 2008 641 644
31. J. Davidson, C. Koro, B. Arondekar, B.H. Lee, and D. Fedder A retrospective analysis of the fasting plasma glucose and glycosylated hemoglobin and pharmacotherapy change patterns among type 2 diabetes mellitus patients Clin Ther 30 2008 287 293 (Pubitemid 351474378)
32. M.C. Riddle, J. Rosenstock, and J. Gerich The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients Diabetes Care 26 2003 3080 3086 (Pubitemid 37339502)
33. Postprandial blood glucose American Diabetes Association Diabetes Care 24 2001 775 778
34. A. Ceriello, S. Colagiuri, J. Gerich, and J. Tuomilehto Guideline for management of postmeal glucose Nutr Metab Cardiovasc Dis 18 2008 S17 S33
35. E. Bonora, G. Corrao, V. Bagnardi, A. Ceriello, M. Comaschi, and P. Montanari Prevalence and correlates of post-prandial hyperglycaemia in a large sample of patients with type 2 diabetes mellitus Diabetologia 49 2006 846 854
36. B. Balkau, M. Shipley, R.J. Jarrett, K. Pyorala, M. Pyorala, and A. Forhan High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study Diabetes Care 21 1998 360 367 (Pubitemid 28101069)
37. E. Barrett-Connor, and A. Ferrara Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men. The Rancho Bernardo Study Diabetes Care 21 1998 1236 1239 (Pubitemid 28365676)
38. J.E. Shaw, A.M. Hodge, M. De Courten, P. Chitson, and P.Z. Zimmet Isolated post-challenge hyperglycaemia confirmed as a risk factor for mortality Diabetologia 42 1999 1050 1054 (Pubitemid 29408800)
39. M. Tominaga, H. Eguchi, H. Manaka, K. Igarashi, T. Kato, and A. Sekikawa Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study Diabetes Care 22 1999 920 924 (Pubitemid 29241045)
40. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria Arch Intern Med 161 2001 397 405
41. F. Cavalot, A. Petrelli, M. Traversa, K. Bonomo, E. Fiora, and M. Conti Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga Diabetes Study J Clin Endocrinol Metab 91 2006 813 819 (Pubitemid 43357744)
42. M. Hanefeld, C. Koehler, F. Schaper, K. Fuecker, E. Henkel, and T. Temelkova-Kurktschiev Postprandial plasma glucose is an independent risk factor for increased carotid intima-media thickness in non-diabetic individuals Atherosclerosis 144 1999 229 235 (Pubitemid 29259984)
43. H. Kawano, T. Motoyama, O. Hirashima, N. Hirai, Y. Miyao, and T. Sakamoto Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery J Am Coll Cardiol 34 1999 146 154
44. L. Monnier, E. Mas, C. Ginet, F. Michel, L. Villon, and J.P. Cristol Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes JAMA 295 2006 1681 1687
45. M. Hanefeld, S. Fischer, U. Julius, J. Schulze, U. Schwanebeck, and H. Schmechel Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up Diabetologia 39 1996 1577 1583 (Pubitemid 26397370)
46. J.L. Chiasson, R.G. Josse, R. Gomis, M. Hanefeld, A. Karasik, and M. Laakso Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial JAMA 290 2003 486 494 (Pubitemid 37430502)
47. U. Zeymer, A. Schwarzmaier-D'assie, D. Petzinna, and J.L. Chiasson Effect of acarbose treatment on the risk of silent myocardial infarctions in patients with impaired glucose tolerance: results of the randomised STOP-NIDDM trial electrocardiography substudy Eur J Cardiovasc Prev Rehabil 11 2004 412 415 (Pubitemid 39491062)
48. M. Hanefeld, M. Cagatay, T. Petrowitsch, D. Neuser, D. Petzinna, and M. Rupp Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies Eur Heart J 25 2004 10 16 (Pubitemid 38055587)
49. K. Esposito, D. Giugliano, F. Nappo, and R. Marfella Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus Circulation 110 2004 214 219 (Pubitemid 38924590)
50. H. Bibra, T. Siegmund, A. Ceriello, M. Volozhyna, and P.M. Schumm-Draeger Optimized postprandial glucose control is associated with improved cardiac/vascular function - comparison of three insulin regimens in well-controlled type 2 diabetes Horm Metab Res 41 2009 109 115
51. I. Raz, P.W. Wilson, K. Strojek, I. Kowalska, V. Bozikov, and A.K. Gitt Effects of prandial versus fasting glycemia on cardiovascular outcomes in type 2 diabetes: the HEART2D trial Diabetes Care 32 2009 381 386
52. L. Monnier, C. Colette, C. Boegner, T.C. Pham, H. Lapinski, and H. Boniface Continuous glucose monitoring in patients with type 2 diabetes: Why? When? Whom? Diabetes Metab 33 2007 247 252 (Pubitemid 47418699)
53. C. Colette, and L. Monnier Acute glucose fluctuations and chronic sustained hyperglycemia as risk factors for cardiovascular diseases in patients with type 2 diabetes Horm Metab Res 39 2007 683 686 (Pubitemid 47492653)
54. L. Monnier, and C. Colette Glycemic variability: should we and can we prevent it? Diabetes Care 31 Suppl 2 2008 S150 S154
55. A. Ceriello Postprandial hyperglycemia and diabetes complications: is it time to treat? Diabetes 54 2005 1 7 (Pubitemid 40105088)